Experimental Protection of Mice Against Lethal Staphylococcus aureus infection by Novel Bacteriophage MR11
The Journal of Infectious Diseases, 2003
Karen E. Cerveny, Angelo DePaola, Donna H. Duckworth, and
Paul A. Gulig
Phage Therapy of Local and Systemic Disease Caused by Vibrio vulnificus in Iron-Dextran-Treated Mice
American Society for Microbiology Infect Immun. 2002 November
J J Bull, Bruce R Levin, Terry DeRouin, Nina Walker, and Craig A Bloch
Dynamics of Success and Failure in Phage and Antibiotic Therapy in Experimental Infections
BioMed Central, August 28, 2002
Biswas, Sankar Adhya, Paul Washart, Brian Paul, Andrei N. Trostel
Bacteriophage Therapy Rescues Mice Bacteremic from a Clinical Isolate of Vancomycin-Resistant Enterococcus faecium
Infection and Immunity, ASM, January 2002
Paul Barrow, Margaret Lovell, and Angelo Berchieri, Jr
Use of Lytic Bacteriophage for Control of Experimental Escherichia coli Septicemia and Meningitis in Chickens and Calves
Clinical and Diagnostic Laboratory Immunology, May, 1998
Treatment of experimental infections of mice with bacteriophages
Journal Medical Microbiology, Oct, 1992
Smith, H.W. and R.
The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages
Journal General. Microbiology, May, 1987
HW, Huggins MB
General Microbiology, Aug, 1983
Smith HW, Huggins MB
Successful treatment of experimental Escherichia coli infections in mice using phage: its general superiority over antibiotics
Journal of General Microbiology, Feb, 1982
Morton, H. E. and Perez-Otero, J. E.
The Increase of Bacteriophage in Vivo During Experimantal Infections with Shigella paradysenteriae, Flexner, in mice
J Bacteriol 47: 475-476. 1944
Ward, W. E.
Protective Action Of VI Bacteriophage In Eberthella Typhi Infections In Mice.
Journal of Infectious Disease: 1942
Copyright (c) Phage Therapy Center 2004-2022